Variant report
Variant | esv3390286 |
---|---|
Chromosome Location | chr2:141504707-141507655 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:141503402..141505492-chr2:141538809..141541757,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs387927 | chr2:141504719-141504720 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs555980974 | chr2:141504742-141504743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs575846800 | chr2:141504746-141504747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576125006 | chr2:141504755-141504756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs75360763 | chr2:141504777-141504778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146020569 | chr2:141504888-141504889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138661943 | chr2:141504901-141504902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs1441451 | chr2:141504920-141504921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs75968536 | chr2:141504946-141504947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs72925883 | chr2:141504947-141504948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs373727318 | chr2:141504957-141504958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs367868344 | chr2:141504980-141504981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563462999 | chr2:141505001-141505002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs410709 | chr2:141505007-141505008 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs189915733 | chr2:141505064-141505065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551686379 | chr2:141505076-141505077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs77676216 | chr2:141505094-141505095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559215719 | chr2:141505105-141505106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533788751 | chr2:141505158-141505159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs544381594 | chr2:141505159-141505160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547477581 | chr2:141505213-141505214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs567375442 | chr2:141505257-141505258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs180888174 | chr2:141505263-141505264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs185936257 | chr2:141505279-141505280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs562774372 | chr2:141505295-141505296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs192026516 | chr2:141505296-141505297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs80293235 | chr2:141505318-141505319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs543217787 | chr2:141505345-141505346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs116314138 | chr2:141505353-141505354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs2218241 | chr2:141505389-141505390 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs12999882 | chr2:141505404-141505405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs114887520 | chr2:141505411-141505412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs144552995 | chr2:141505423-141505424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs12999916 | chr2:141505455-141505456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184005155 | chr2:141505462-141505463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs188550342 | chr2:141505467-141505468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs148531915 | chr2:141505481-141505482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs551355746 | chr2:141505482-141505483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs531102818 | chr2:141505494-141505495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs68114789 | chr2:141505542-141505543 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs527241336 | chr2:141505568-141505569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs377287046 | chr2:141505638-141505639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs370410626 | chr2:141505662-141505663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs71348757 | chr2:141505691-141505692 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs374648958 | chr2:141505693-141505694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs201715706 | chr2:141505705-141505706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs67552672 | chr2:141505789-141505790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs372415441 | chr2:141505859-141505860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs70988423 | chr2:141505863-141505864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs70988424 | chr2:141505870-141505871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma | 21080181 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Autism | 22543975 | CNVD |
Cancer | 20164920 | CNVD |
Hypertension | 22686481 | CNVD |
Hypospadia | 22686481 | CNVD |
Intellectual disability | 22686481 | CNVD |
Omphalocele | 22686481 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Prostate cancer | 22341455 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:141504600-141505600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr2:141504800-141505600 | Enhancers | GM12878-XiMat | blood |
3 | chr2:141505600-141508400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |